![Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37]](https://cedclinic.com/wp-content/uploads/2026/07/ced-pexels-5021600-150x150.jpg "Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37] 24")
The Endocannabinoid System and Myelin Regeneration: A Clinical Breakdown
A new preclinical study from Complutense University has found that CB1 receptor myelin repair mechanisms depend on intact endocannabinoid signaling at a critical cellular window. Researchers removed CB1 receptors specifically from newly formed…
Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice.
The endocannabinoid system (ECS) and the autophagy receptor p62 are both implicated in metabolic regulation and obesity, yet the mechanisms linking these pat...
Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia.
The relationship between the endocannabinoid system and the emergence and treatment of schizophrenia-related symptoms continues to be a topic of significant ...
Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice.
The endocannabinoid system (ECS) and the autophagy receptor p62 are both implicated in metabolic regulation and obesity, yet the mechanisms linking these pat...
CBD Gummies and Psychosis: What the Evidence Shows for Everyday Use
CBD gummies and psychosis risk remain an area with limited and contradictory evidence. Clinicians must assess psychosis risk carefully when counseling patients using CBD gummies. Understanding the clinical evidence on CBD gummies and psychosis risk is…
Targeting CB1 and TRPM8 Receptors to Counteract CD8+ T Cell Exhaustion
This study highlights the role of cb1 receptor antagonist cancer immunotherapy in reducing exhaustion markers on CD8+ T cells. Blocking CB1 receptors may help maintain T cell function against tumors. These findings suggest potential benefits of CB1…
Aelis Farma Reports Its 2025 Annual Financial Results and Confirms Its 2026 Outlook
Aelis Farma announced its financial results for 2025, highlighting progress in cannabis use disorder treatment development. The 2026 outlook confirms continued clinical trial advancements. This report focuses on Aelis Farma financial results 2025 and…
Loss of dystrophin reduces CB1 receptor expression and endocannabinoid-dependent synaptic plasticity in the cerebellar cortex.
Dystrophin endocannabinoid system disruption reduces CB1 receptor expression in the cerebellar cortex. This affects endocannabinoid-dependent synaptic plasticity, relevant to Duchenne Muscular Dystrophy. Understanding this mechanism may inform future…
Activation of Cannabinoid Receptor 1 Enhances Wound Healing by Promoting the Proliferative Phase
Activation cannabinoid receptor type 1 plays a crucial role in wound healing by promoting the proliferative phase. This process involves increased fibroblast proliferation and enhanced extracellular matrix synthesis. Understanding this mechanism may…
Targeting Mechanosensitive CB1 with Isoflavone Prodrugs to Reduce Atherosclerosis
Atherosclerotic endothelial dysfunction is a key factor in cardiovascular disease progression. Targeting mechanosensitive cannabinoid receptor 1 with isoflavone prodrugs offers a novel approach to reduce vascular inflammation. This strategy may improve…